PAVM
$10.39
PAVmed Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for u...
Recent News
PAVmed Inc (PAVM) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Financial ...
PAVmed Inc (PAVM) reports significant strides in debt restructuring, strategic partnerships, and technology innovation, despite facing ongoing financial challenges.
PAVmed (PAVM) Upgraded to Strong Buy: Here's Why
PAVmed (PAVM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
PAVmed plans to license Duke’s oesophageal imaging technology
A PAVmed subsidiary seeks to obtain exclusive worldwide licensing rights for Duke University’s a/LCI + OCT technology.
PAVmed subsidiary Veris Health partners with Ohio State University cancer center
PAVmed’s (PAVM) majority-owned digital health subsidiary Veris Health has entered into a strategic partnership agreement with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, or OSUCCC – James, a National Cancer Institute-Designated Comprehensive Cancer Center. This agreement follows the successful completion of a pilot program which enrolled patients across several OSUCCC – James cancer care service lines on the Ve
PAVmed Inc (PAVM) Q1 2025 Earnings Call Highlights: Strategic Expansion and Financial Fortification
PAVmed Inc (PAVM) strengthens its financial position and explores new opportunities in biopharma amidst ongoing challenges.